Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,676 | -25,098 | -18,077 | -9,128 | -43,002 |
| Depreciation Amortization | 162 | 130 | 97 | 55 | 396 |
| Accounts payable and accrued liabilities | -724 | -1,387 | -895 | -1,056 | 2,224 |
| Other Working Capital | -5,019 | -5,579 | -3,381 | -4,581 | -2,902 |
| Other Operating Activity | 3,526 | 2,479 | 2,449 | 3,109 | 103 |
| Operating Cash Flow | $-38,731 | $-29,455 | $-19,807 | $-11,601 | $-43,181 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -48 |
| Purchase Of Investment | -35,683 | -24,352 | -18,927 | -7,942 | -42,463 |
| Sale Of Investment | 36,930 | 31,450 | 20,470 | 7,730 | 45,836 |
| Investing Cash Flow | $1,247 | $7,098 | $1,543 | $-212 | $3,325 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,367 | 18,614 | 18,022 | 10,053 | 56,277 |
| Other Financing Activity | 14,817 | -1,642 | -1,642 | -1,642 | -9,356 |
| Financing Cash Flow | $42,184 | $16,972 | $16,380 | $8,411 | $46,921 |
| Beginning Cash Position | 22,186 | 22,186 | 22,186 | 22,186 | 15,121 |
| End Cash Position | 26,886 | 16,801 | 20,302 | 18,784 | 22,186 |
| Net Cash Flow | $4,700 | $-5,385 | $-1,884 | $-3,402 | $7,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,731 | -29,455 | -19,807 | -11,601 | -43,181 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -48 |
| Free Cash Flow | -38,731 | -29,455 | -19,807 | -11,601 | -43,229 |